Iván Cornella Taracido, PhD
About Iván Cornella Taracido, PhD
Iván Cornella-Taracido Career Overview
Iván Cornella-Taracido, PhD, currently holds the position of Vice President of Translational Chemical Biology. His extensive career includes significant roles at prominent pharmaceutical companies like Cedilla Therapeutics, Merck, AstraZeneca, and Sanofi. His expertise lies in establishing and managing chemical biology and proteomics teams, as well as contributing to target identification and mode of action elucidation. Additionally, he has acted as a consultant for several start-ups and biotech firms, showcasing his broad influence in the field.
Educational Background of Iván Cornella-Taracido
Iván Cornella-Taracido holds a Ph.D. in organic chemistry from the Universidade da Coruña in Spain. He further expanded his expertise by earning an Executive Certificate in innovation from the MIT Sloan School of Management. His postdoctoral work includes research at the Institute of Chemistry & Cell Biology of Harvard Medical School, now known as the Broad Institute of MIT and Harvard, where he was a National Cancer Institute Initiative for Chemical Genetics Research Fellow. Additionally, he completed postdoctoral work at the chemistry department of Boston College.
Professional Contributions of Iván Cornella-Taracido
At Novartis, Iván Cornella-Taracido was a founding member of the NIBR target identification and mode of action elucidation (TIDMoA) platform. He established and managed chemical biology and proteomics teams, driving advancements in these critical areas. His contributions extend beyond his primary roles, as he has also consulted on target and drug discovery for numerous start-ups and biotech firms, highlighting his broad impact on the industry.
Iván Cornella-Taracido's Involvement in Conferences and Non-Profit Organizations
Iván Cornella-Taracido is active in the scientific community, serving as a volunteer committee member for the Chemistry in Cancer Research section of the American Association for Cancer Research (AACR). He also serves as an ambassador for SeedingLabs, a non-profit organization. Furthermore, he has been an invited speaker, organizer, and chair at numerous international conferences, focusing on drug discovery, phenotypic screening, target identification, chemical biology, and proteomics.